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Edited by Robert BaroukiAbstract 15-Deoxy-D12,14-prostaglandin J2 (15d-PGJ2) has
been identiﬁed as a natural ligand for peroxisome proliferator-
activated receptor (PPAR) c to promote adipogenesis. However,
it remains elusive about the ability of PPARc-expressing adipo-
cytes to produce PGJ2 series and the role in the life cycle of adi-
pocytes. Here, we developed an enzyme-linked immunosorbent
assay speciﬁc for 15d-PGJ2. The analysis using this method re-
vealed the increase in the endogenous synthesis of immunoreac-
tive 15d-PGJ2 in cultured adipocytes during the maturation
phase. Further studies using cyclooxygenase inhibitors clariﬁed
the contribution of endogeous 15d-PGJ2 produced by mature
adipocytes to upregulation of fat storage in an autocrine manner.
 2006 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Adipocytes play a crucial role in the storage of fats and
mobilization of free fatty acids, and furthermore serve as endo-
crine cells. Moreover, the changes in the quality of adipo-
cytes are responsible for the generation of insulin resistance
and other life-style diseases [1]. Certain nuclear receptors are
involved in the control of a series of events leading to adipo-
genesis as well as the increased size of adipocytes in obesity.
Of these, peroxisome proliferator-activated receptor (PPAR)
c, a member of the nuclear hormone superfamily, is a master
regulator of the diﬀerentiation of adipocytes [2,3]. Since this
receptor is a ligand-activated transcription factor, the endoge-
nous ligands should be provided for the activation of PPARc
in adipose tissues. Originally, PPAR-related receptors were
found to be activated by antidiabetic drugs. Later, certain fattyAbbreviations: 15d-PGJ2, 15-deoxy-D
12,14-prostaglandin J2; PG, pros-
taglandin; PPAR, peroxisome proliferator-activated receptor; ELISA,
enzyme-linked immunosorbent assay; COX, cyclooxygenase; L-PGDS,
lipocalin-type prostaglandin D synthase; H-PGDS, hematopoietic
prostaglandin D synthase; RT-PCR, reverse transcriptase-polymerase
chain reaction; RP-HPLC, reverse-phase high-performance liquid
chromatography; GLUT, glucose transporter; cPLA2, cytosolic phos-
pholipase A2
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doi:10.1016/j.febslet.2006.11.049acids and some eicosanoids including prostagladins (PGs) of J2
series were found to activate PPARs as natural ligands [4–6].
In adipose tissue in vivo, true endogenous ligands for PPARc
have not been identiﬁed with certainty because there are a di-
verse group of lipids and related compounds as candidate mol-
ecules. Recent studies have shown that PGs play a variety of
roles in adipogenesis through cell-surface receptors or nuclear
receptors in adipocytes [4,7]. Moreover, adipocytes can pro-
duce diﬀerent types of PGs that exert opposite eﬀects on adipo-
genesis [8–10].
The arachidonate cyclooxygenase (COX) pathway generates
PGD2 that readily undergoes non-enzymatic dehydration to
generate biologically active PGJ2 derivatives including 15-
deoxy-D12,14-PGJ2 (15d-PGJ2) and D
12-PGJ2 through PGJ2
as an intermediate [11,12]. Among the PGJ2 derivatives, 15d-
PGJ2 has been shown to be a potent natural activator for
PPARc [5,6]. It has been diﬃcult to determine whether 15d-
PGJ2 is synthesized in PPARc-expressing adipocytes or trans-
ported to the target adipocytes in adipose tissues in vivo. For
studying the regulation of the arachidonate cascade in adipo-
cytes, we have been making use of cultured mouse preadipo-
genic 3T3-L1 cells that are a useful system for monitoring
the life cycle of adipocyts [7–10]. More recently, we [9] and
other group [13,14] have shown the selective gene expression
of lipocalin-type PGDS (L-PGDS) without detecting the other
hematopoietic PGDS (H-PGDS) in cultured 3T3-L1 adipo-
cytes. However, the quantitative determination of PGJ2 series
has yet to be explored in life cycle of adipocytes. Moreover, it
remains unclear how the arachidonate COX pathway is regu-
lated in adipocyts and what the roles of endogenous PGJ2 ser-
ies are in the life cycle of adipocytes.
Here, we raised a speciﬁc antiserum for 15d-PGJ2 and devel-
oped a sensitive enzyme-linked immunosorbent assay (ELISA)
for the quantitative determination of 15d-PGJ2 produced by
3T3-L1 adipocytes. Furthermore, we provide the evidence that
endogenous 15d-PGJ2 and the associated molecule can upreg-
ulate adipogenesis in an autocrine manner.2. Materials and methods
2.1. Materials
Authentic prostanoids, aspirin, SC-560, and NS-398 were purchased
from Cayman Chemical (Ann Arbor, MI, USA). Triglyceride E-Test
Kit was supplied by Wako (Osaka, Japan), and L-column ODS
(4.6 · 250 mm) for reverse-phase high-performance liquid chromato-
graphy (RP-HPLC) was from Chemicals Evaluation and Research
Institute (Tokyo, Japan). Other materials used for cell culture, reverseblished by Elsevier B.V. All rights reserved.
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obtained as described before [9,10,15].
2.2. Cell culture of 3T3-L1 cells and adipocyte diﬀerentiation
The mouse 3T3-L1 cells, a preadipogenic cell line (JCRB9014), were
plated at 5 · 104 cells/ml in the growth medium containing Dulbecco’s
modiﬁed Eagle’s medium with 25 mMHEPES, 10% fetal bovine serum
and 200 lM ascorbic acid, and grown until conﬂuence. The resulting
conﬂuent cells were exposed to the diﬀerentiation medium containing
1 lM dexamethasone, 0.5 mM 3-isobutyl-1-methylxanthine, and
10 lg/ml insulin. After 45 h, the culture medium was replaced with the
maturationmediumcontaining 5 lg/ml insulin, and refed every twodays
to promote the maturation of adipocytes as described before [9,10]. The
test compounds were dissolved in ethanol as a vehicle and added to the
culture medium. The volume of ethanol was adjusted to 0.2%.
2.3. Gene expression analysis
Total RNA was extracted from cultured 3T3-L1 adipocytes at diﬀer-
ent stages of the maturation phase by the method of acid guanidium
thiocyanate/phenol/chloroform mixture [16]. For the speciﬁc detection
of the target genes, total RNA (1 lg) was subjected to the analysis of
RT-PCR using M-MLV reverse transcriptase (RNase H minus, point
mutant) and 1· PCRMaster Mix (Promega) according to our previous
methods [9,10]. Oligonucleotides used as 5 0-primer and 3 0-primers are
listed in Table 1. The ampliﬁed DNA fragments were separated by
1.5% agarose gel electrophoresis. DNA sequences of the ampliﬁed
DNA fragments were determined as reported before [10].
2.4. ELISA for 15-PGJ2
For generating the antiserum speciﬁc for 15d-PGJ2, BALB/c mice
were immunized with the conjugate of 15d-PGJ2 and bovine serum
albumin according to our earlier methods [15,17,18]. For the assay
of 15d-PGJ2, the conjugate of 15d-PGJ2 and c-globulin was prepared
and coated in a 96-well. The resulting immobilized antigen was allowed
to react competitively with the antiserum for 15d-PGJ2 in the presence
or absence of standards or samples.
2.5. RP-HPLC of PG extracts followed by immunological detection of
15d-PGJ2
The maturation medium of 3T3-L1 adipocytes after 12–14 days was
collected and used for the extraction of PGs. The collected medium
(1 ml) was mixed with 1 ml of 1 M sodium acetate buﬀer (pH 3.5),
and then PGs were extracted with 2 ml of ethyl acetate. The extractsTable 1
Oligonucleotides of sense and antisense primers used for RT-PR
Name Size (mer) Sequence
5 0-Primers
PPARc 20 5 0-GAACCTGCATCTCCACCTTA-3 0
PLA2a 21 5 0-AAATAGGATGAGCATGACCCT-30
COX-1 20 5 0-GGGACCAAAGGGAAGAAACA-3 0
COX-2 20 5 0-GAGATGATCTACCCTCCTCA-3 0
L-PGDS 20 5 0-GACAAGTTCCTGGGGCGCTG-3 0
GLUT-4 20 5 0-CCTCATGGGCCTAGCCAATG-3 0
Adiponectin 21 5 0-GCCGTGATGGCAGAGATGGCA-30
Leptin 21 5 0-AGTCCAGGATGACACCAAAAC-30
b-Actin 21 5 0-GTTTGAGACCTTCAACACCCC-30
3 0-Primers
PPARc 20 5 0-TTCAGCTTGAGCTGCAGTTC-3 0
cPLA2a 21 5 0-AAGGAATCCTGAGAGCTGAAG-30
COX-1 21 5 0-AACCCCATAGTCCACCAGCAT-30
COX-2 21 5 0-CCCCTTCACATTATTGCAGAT-30
L-PGDS 20 5 0-CTACTGTAGAGGGTGGCCAT-3 0
GLUT-4 21 5 0-TAGCTCATGGCTGGAACCCGT-30
Adiponectin 21 5 0-GCCTTGTCCTTCTTGAAGAGG-30
Leptin 21 5 0-GTTGGATGTTAGCCCTGAATG-30
b-Actin 21 5 0-GGAGGAGCAATGATCTTGATC-30
The sizes of ampliﬁed cDNA fragments using RNA from 3T3-L1 cells
were as follows: PPARc, 1032 bp; cPLA2a, 633 bp; COX-1, 768 bp;
COX-2, 909 bp; L-PGDS, 344 bp; GLUT-4, 774 bp; adiponectin,
392 bp; leptin, 423 bp; b-actin, 630 bp.were analyzed by RP-HPLC on the Waters HPLC system equipped
with a 600 controller, 600 pump and Waters 2996 photodiode array
detector to which a L-column ODS (4.6 · 250 mm) was connected.
The column was eluted with a mobile phase of acetonitrile/17 mM
phosphoric acid (60:40, v/v) at a ﬂow rate of 1 ml/min. The peaks of
PGD2, D
12-PGJ2, and 15d-PGJ2 were detectable by monitoring the
absorbance at 230 nm. The resulting eluates were collected every
1 min, and subjected to the immunological detection of 15d-PGJ2 by
ELISA after the extraction of prostanoids.
2.6. Determination of cellular levels of triacylglycerol and protein
The accumulation of triacylglycerols was determined using triglycer-
ide E-Test Kit as described before [9,10]. The amount of cellular pro-
teins was also measured according to our previous methods [9,10].3. Results
3.1. Gene expression of adipocyte-speciﬁc markers and isoformic
enzymes in arachidonate COX pathway leading to the
generation of PGJ2 derivatives
The generation of PGJ2 derivatives requires the arachidonate
COX pathway leading to the production of PGD2. Recently,
we found the selective gene expression of L-PGDS in cultured
3T3-L1 adipocytes without detecting H-PGDS [9]. As shown
in Fig. 1, the gene expression of COX-2 at 3 h was clearly higher
than that at 24 h, indicating the transient expression of COX-2
as described [19]. Instead, cytosolic phospholipase A2 (cPLA2)a
and COX-1 were constitutively expressed without being af-
fected by the change with the maturation medium. On the other
hand, the gene expression of L-PGDS gradually increased and
became more evident in the later maturation phase.
Under the our experimental conditions, we also conﬁrmed
the increased gene expression of the adipocyte-speciﬁc markers
including PPARc, glucose transporter (GLUT)-1, GLUT-4,
and adiponectin (data not shown). Those expression levels
were more evident after two days of the maturation phase.
3.2. Development of ELISA speciﬁc for 15d-PGJ2
To determine speciﬁcally the endogenous formation of 15d-
PGJ2 in adipocytes, we established a highly sensitive ELISA
speciﬁc for 15d-PGJ2. According to the standard curve, the
amount of 15d-PGJ2 can be determined from 1.6 pg to
33.5 ng in an assay with the 50% displacement of 0.22 ng
(Fig. 2). Cross-reactivity of the antiserum with other prosta-Fig. 1. Gene expression of isoformic biosynthetic enzymes in the
arachidonate COX pathway in cultured adipocytes during the matu-
ration phase. 3T3-L1 cells were plated at 5 · 104 cells/ml in a 60-mm
Petri dish containing 4 ml of the culture medium, grown to the
conﬂuence, diﬀerentiated, and matured to terminal diﬀerentiation.
Total RNA was extracted from cultured adipocytes at 3 h or 24 h after
the change with fresh maturation medium every two days and
subjected to the RT-PCR analysis of the desired genes.
Fig. 2. Standard curve of ELISA for 15d-PGJ2. The assay was
performed in the presence of various amounts of authentic 15d-PGJ2.
Fig. 3. Synthesis of 15d-PGJ2 by cultured adipocytes during the
maturation phase. 3T3-L1 cells were plated at 5 · 104 cells/ml in a 35-
mm Petri dish containing 2 ml of the culture medium, and grown to the
conﬂuence, diﬀerentiated, and matured to terminal diﬀerentiation. At
the indicated time of the maturation phase, the maturation medium
supplemented either with vehicle, 500 lM aspirin, or 1 lM indometh-
acin was refed every two days, collected, and subjected to the
determination of the amount of 15d-PGJ2 by ELISA. Data represent
the means ± S.E.M. of three independent experiments. *P < 0.05
versus vehicle-treated cells on day 0–2; #P < 0.05 versus vehicle-
treated cells at the same periods (Student’s t-test).
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PGJ2 and D
12-PGJ2 showed the cross-reactions of 6.46% and
1.69%, respectively. Other prostanoids exhibited those of less
than 1%. We also conﬁrmed the precision and accuracy of
our ELISA for the application to the measurement of 15d-
PGJ2 in the maturation medium of cultured 3T3-L1 adipocytes.
3.3. Endogenous synthesis of 15d-PGJ2 during the maturation
phase of adipocytes
Our ELISA developed for 15d-PGJ2 was applied to the
determination of endogenous synthesis of 15d-PGJ2 during
the maturation phase for 14 days in cultured 3T3-L1 adipo-
cytes in the presence or absence of 500 lM aspirin and 1 lM
indomethacin, well-known general COX inhibitors. The result-
ing maturation medium was harvested every two days and sub-
jected to the immunological determination of 15d-PGJ2
(Fig. 3). The ability of cultured adipocytes to synthesize immu-
noreactive 15d-PGJ2 was found to increase gradually with the
progression of the maturation phase. However, the treatment
with aspirin or indomethacin resulted in the signiﬁcant reduc-
tion in the levels of 15d-PGJ2, indicating the endogenous
synthesis of 15d-PGJ2 through the action of COX isoforms.
The measurable amounts of immunoreactive 15d-PGJ2 by
our ELISA included both the free and covalently bound form.
The majority was the free form in the culture medium since
almost 70% of the immunoreactive 15d-PGJ2 was extractableTable 2
Cross-reaction of mouse antiserum for 15-deoxy-D12,14-PGJ2 with
other related prostanoids
Prostanoids and related compounds Cross-reaction (%)
15-Deoxy-D12,14-PGJ2 100
PGJ2 6.46 ± 0.38
D12-PGJ2 1.69 ± 0.31
8-iso-PGF2a 0.09 ± 0.01
PGD2 0.07 ± 0.01
PGE2 <0.01
PGF2a <0.01
11b-PGF2a <0.01
PGA2 <0.01
Arachidonic acid <0.01
Thromboxane B2 <0.01
Data represent the means ± S.E.M. of three independent experiments.with ethyl acetate at pH 3.5 as determined by our ELISA.
The remaining immunoreactive 15-PGJ2 indicates the cova-
lently bound form as well as some recovery loss.
As described above, we found the increased production of
15d-PGJ2 by ELISA in later maturation phase. To conﬁrm fur-
thermore the immunoreactive 15d-PGJ2, the prostanoids were
extracted and separated by RP-HPLC (Fig. 4). Moreover, the
resulting eluates were subjected to ELISA for 15d-PGJ2. The
immunoreactive peak corresponding to 15d-PGJ2 was the most
predominant in the maturationmedium after 12–14 days. Other
immunoreactive peaks coeluting with PGJ2 and D
12-PGJ2 were
also detectable, but those peaks were much lower than that of
15d-PGJ2. Since our antiserum for 15d-PGJ2 was much less
reactive with other PGJ2 derivatives, the immunoreactive peaks
do not necessarily reﬂect the relative amounts of PGJ2 series.
3.4. Role of endogenous 15d-PGJ2 in fat storage during the
maturation phase
In order to deﬁne the role of endogenous 15d-PGJ2 in adipo-
genesis during the maturation phase, the cells were cultured for
14 days by replacing the maturation medium every two days
with or without 500 lM aspirin. The treatment of cultured adi-
pocytes with aspirin during the maturation phase resulted in
the signiﬁcant decrease in the amount of triacylglycerols as evi-
dent after 6 days (Fig. 5). Additionally, the inhibitory eﬀect of
aspirin on the accumulation of fats in adipocytes was
conﬁrmed by Oil Red O staining (Fig. 6). Moreover, we con-
ﬁrmed the marked reduction in the amounts of triacylglycerols
in mature adipocytes with 1 lM indomethacin (Fig. 5).
To support the above results, we examined whether exoge-
nous PGD2 and its dehydration products, PGJ2 derivatives,
might reverse the attenuating eﬀect of aspirin on adipogenesis
(Fig. 7). All of PGD2, 15d-PGJ2, and D
12-PGJ2 at 0.1 lM or
1 lMwere found to be eﬀective in the upregulation of adipogen-
esis in the presence of aspirin during the maturation phase.
Fig. 4. RP-HPLC of prostanoids extracted from the maturation
medium of cultured adipocytes. (A) Authentic prostanoids (each
100 ng) was eluted and detected at 230 nm. (B) 3T3-L1 cells were
cultured until the maturation phase, and the prostanoids were
extracted from the maturation medium of days 12–14. The extracts
corresponding to 8 ng of immunoreactive 15d-PGJ2 were separated by
RP-HPLC, and the resulting eluates were subjected to the immuno-
logical detection by ELISA for 15d-PGJ2.
Fig. 5. Suppression of adipogenesis by aspirin in adipocytes during the
maturation phase. 3T3-L1 cells were cultured, diﬀerentiated, and
matured to adipocytes as in Fig. 3. During the maturation phase, the
cells were treated either with vehicle, 500 lM aspirin, or 1 lM
indomethacin. The maturation medium with or without aspirin and
indomethacin was replaced every two days for total 14 days. Then, the
amount of triacylglycerols was determined in mature adipocytes. A
accumulation of triacylglycerols in mature adipocytes. Data represent
the means ± S.E.M. of three independent experiments. *P < 0.05
versus vehicle-treated cells on day 0; #P < 0.05 versus vehicle-treated
cells at the same periods (Student’s t-test).
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However, the eﬀect was much less than PGJ2 series. In sharp
contrast, other prostanoids showed no signiﬁcant eﬀects along
with aspirin. These ﬁndings provide the evidence for the involve-ment of endogenous 15d-PGJ2 in the stimulation of adipogene-
sis in mature adipocytes in an autocrine manner. In addition,
endogenous D12-PGJ2 could also contribute to the stimulated
accumulation of triacylglycerols during the maturation process.
Moreover, the action of the COX inhibitors and 15d-PGJ2
was evaluated on the expression of adipocyte-speciﬁc genes
during the maturation phase (Fig. 8). The analysis of the
mRNA levels of the target genes revealed that the addition of
1 lM indomethacin appreciably attenuated the expression of
GLUT-4, adiponectin, and leptin (Fig. 8A). On the other hand,
1 lM 15d-PGJ2 was found to be eﬃcacious to enhance the gene
expression of adiponectin and leptin in the presence of aspirin
(Fig. 8B). The stimulatory eﬀect of 15d-PGJ2 was in sharp con-
trast with ineﬀective PGF2a. These ﬁndings supported the
upregulation of fat storage by endogenous 15d-PGJ2 through
adipogenesis associated with the terminal diﬀerentiation.4. Discussion
In this study, we were successful for developing a sensitive
ELISA speciﬁc for 15d-PGJ2 (Fig. 2). This immunological assay
allowed us to determine quantitatively the endogenous 15d-
PGJ2 in adipocytes during thematuration phase. The formation
of immunoreactive 15d-PGJ2 was found to gradually increase in
later maturation phase (Fig. 3). We conﬁrmed that the peak of
immunoreactive 15d-PGJ2 corresponded to that of the authen-
tic compound by RP-HPLC (Fig. 4). Since our antiserum used
for ELISA is much more speciﬁc for 15d-PGJ2 than other re-
lated PGJ2 and D
12-PGJ2 (Table 2), the immunological detec-
tion of other PGJ2 series in our samples was substantially
minor as evident in Fig. 4. However, the formation of D12-
PGJ2 cannot be excluded in mature adipocytes. More recently,
other groups have attempted to determine the biosynthesis of
15d-PGJ2 in 3T3-L1 adipocytes by liquid chromatography-mass
spectrometry [20] or immunological assays [14]. They reported
the failure to show the increased level of 15d-PGJ2 during adipo-
cyte diﬀerentiation. The reasons of the discrepancy with our re-
sults could be explained by the diﬀerences in culture conditions
and the sampling periods. As diﬀerent from others, we collected
the maturation medium in cultured adipocytes every two days
until 14th day after the maturation phase, and found the highest
levels of 15d-PGJ2 on day 14 in the later maturation phase.
Since 15d-PGJ2 is spontaneously formed by the dehydration
reaction of PGD2, the biosynthesis of those compounds
requires three enzymatic reactions involving PLA2 to release
free arachidonic acid from membrane phospholipids, COX
to oxygenate free arachidonic acid to PGH2, and terminal
PGD synthase to isomerize PGH2 to PGD2. With respect to
the isoformic enzymes of the COX pathway, we found that
cPLA2a was constitutively expressed in adipocytes (Fig. 1).
Alternatively, the gene expression of two types of COX iso-
forms was characterized by constitutive COX-1 and inducible
COX-2 as evident at 3 h after replacing with the fresh matura-
tion medium. In contrast, gradual increase in the levels of L-
PGDS mRNA was more pronounced in later maturation
phase, indicating the ability of adipocytes to form PGD2 as
a precursor for PGJ2 series as we suggested before [9]. More-
over, we examined the eﬀect of SC-560, a speciﬁc COX-1,
and NS-398, a COX-2 inhibitor on the synthesis of 15d-PGJ2
by mature adipocytes (data not shown). However, the both
COX inhibitors are essentially eﬀective and additive in block-
Fig. 6. Microscopic and macroscopic views of adipocytes after 12 days of the maturation phase. The cultured cells were treated every two days with
the fresh maturation medium with or without 500 lM aspirin. For the microscopic views, the cultured adipocytes were observed by phase-contrast
microscopy without staining and diﬀerential-interference microscopy after staining with Oil Red O at ·200 magniﬁcation. For the macroscopic views,
the cultured cells in 35-mm Petri dishes were stained with Oil Red O.
Fig. 7. Eﬀect of prostanoids together with aspirin on the accumulation
of triacylglycerols in adipocytes during the maturation phase. 3T3-L1
cells were cultured, diﬀerentiated, and matured to adipocytes as in
Fig. 3. During the maturation phase, the cells were treated with either
of prostanoids together with 500 lM aspirin. The maturation medium
with the compounds was replaced every two days for total 12 days,
after which the amount of triacylglycerols was determined in mature
adipocytes. Data represent the means ± S.E.M. of three independent
experiments. *P < 0.05 versus vehicle-treated cells; #P < 0.05 versus
cells treated with aspirin alone (Student’s t-test).
Fig. 8. Expression of adipocyte-speciﬁc genes during the maturation
phase in the presence of COX inhibitors or prostanoids. 3T3-L1 cells
were plated, grown to the conﬂuence, diﬀerentiated, and matured to
adipocytes as in Fig. 1. During the maturation phase, the cells were
treated with or without 1 lM indomethacin. The resulting maturation
medium was replaced every two days for total 12 days (A). Alterna-
tively, the cells were cultured in the maturation medium with or
without 500 lM aspirin, 1 lM PGF2a, and 1 lM 15d-PGJ2 by
replacing every two days for total 6 days (B). After these treatments,
total RNA was extracted from the treated cells and subjected to the
analysis of mRNA levels of GLUT-4, adiponectin, leptin, and b-actin
(reference).
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tribution of both COX isoforms.
Several lines of evidence support the contribution of endo-
genous 15d-PGJ2 to the upregulation of the accumulation of
6890 Md.A. Mazid et al. / FEBS Letters 580 (2006) 6885–6890triacylglycerols in adipocytes during the maturation phase. At
ﬁrst, aspirin and indomethacin, COX inhibitors, signiﬁcantly
suppressed the endogenous generation of 15d-PGJ2 (Fig. 3).
This inhibition was accompanied by the suppression of fat
storage in adipocytes in the maturation phase (Figs. 5 and
6). Furthermore, the decrease in the stored fats in the presence
of aspirin was reversed by the treatment with PGD2 and its
dehydration products, PGJ2 series including 15d-PGJ2 and
D12-PGJ2 (Fig. 7). We conﬁrmed by means of ELISA and
TLC that authentic PGD2 underwent signiﬁcantly the conver-
sion to PGJ2 derivatives 6 h after the incubation at 37 C in the
maturation medium. Our studies revealed that 15d-PGJ2 was
present predominantly as a free form that attached to proteins
from which more than 70% of 15d-PGJ2 can be extracted with
ethyl acetate from the medium at acidic pH (data not shown).
The action of endogenous 15d-PGJ2 to stimulate the storage of
fats would be explained by the activation of PPARc as a po-
tent agonist [5,6]. This idea was supported by the stimulatory
eﬀect of troglitazone, a well-known speciﬁc PPARc agonist
under the same culture conditions (data not shown). However,
it remains unclear about the implication of covalent binding of
this compound to cellular proteins in the upregulation of fat
storage in our system.
The present study also conﬁrmed that the eﬀect of 15d-PGJ2
was linked with the terminal diﬀerentiation during the matura-
tion phase based on our data (Fig. 8). COX inhibitors such as
indomethacin and aspirin were eﬀective in inhibiting the
expression of adipocyte-speciﬁc genes such as GLUT-4, adipo-
nectin, and leptin. On the other hand, exogenous 15d-PGJ2
upregulated the gene expression of those adipocyte markers
in the presence of aspirin. These ﬁndings support the idea that
endogenous 15d-PGJ2 was formed in PPARc-expressing adi-
pocytes and contributed to the upregulation of adipogenesis
in an autocrine manner during the maturation phase. More-
over, it is also conceivable that D12-PGJ2 would also contribute
to the increased adipogenesis. Alternatively, we found that
exogenous PGE2 reversed the inhibitory eﬀect of aspirin on
adipogenesis (Fig. 7). However, we failed to detect the in-
creased formation of the endogenous PGE2 in the maturation
phase as reported recently [10], suggesting no contribution of
endogenous PGE2 in our experimental systems.
In conclusion, using a sensitive and speciﬁc ELISA for 15d-
PGJ2, we clearly revealed the ability of adipocytes during the
later maturation phase to synthesize increasingly endogenous
15d-PGJ2 through the arachidonate COX pathway, which
contributed to the stimulated accumulation of fats through
adipogenesis in an autocrine manner. These ﬁndings provide
useful information for the further studies on the regulation
of the biosynthesis of endogenous PGJ2 series and the roles
in adipose tissues in vivo.
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